COMPOUNDS† | FR50†† | LARVAL MORTALITY (%) | PUPAL MORTALITY (%) | MALFORMED ADULTS (%) |
1 | 1.15 ± 0.34 | 5 | 0 | 95 |
2 | 1.02 ± 0.20 | 60 | 0 | 40 |
3 | 0.98 ± 0.13 | 0 | 5 | 95 |
4 | 1.02 ± 0.28 | 85 | 0 | 15 |
5 | 0.99 ± 0.15 | 100 | 0 | 0 |
6 | 0.88 ± 0.23 | 15 | 0 | 85 |
7 | 0.97 ± 0.25 | 5 | 0 | 95 |
8 | 0.89 ± 0.22 | 20 | 0 | 80 |
9 | 0.81 ± 0.18 | 70 | 0 | 30 |
10 | 0.99 ± 0.19 | 45 | 0 | 55 |
11 | 1.13 ± 0.42 | 5 | 0 | 95 |
12 | 1.13 ± 0.37 | 10 | 0 | 90 |
13 | 0.97 ± 0.16 | 70 | 0 | 30 |
14 | 0.68 ± 0.10 | 40 | 5 | 55 |
15 | 0.58 ± 0.13 | 40 | 0 | 60 |
16 | 0.93 ± 0.16 | 65 | 0 | 35 |
17 | 0.94 ± 0.14 | 65 | 0 | 35 |